Physiologically based pharmacokinetic modelling to support the development of a sustained-release formulation for the treatment of cryptococcal meningoencephalitis: An MIDD case study

ConferenceInfectious diseasesMIDDPBPK-QSPProgram strategies and efficienciesSpecial populations